Evidence map›Paper›PMID 35745533›Full record

ReviewPathogens (Basel, Switzerland)2022

Paulina Paprocka, Bonita Durnaś, Angelika Mańkowska, Grzegorz Król, Tomasz Wollny, Robert Bucki

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 60 citations in OpenAlex.

  1. Quinolone resistance of Pseudomonas aeruginosa isolated from hospital infections and MexAB-OprM efflux pumps.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Colistin-resistantAnnals of medicine and surgery (2012) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Viruses · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Paulina PaprockaDepartment of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University, IX Wieków Kielc 19A, 25-317 Kielce, Poland.ORCID 0000-0002-3626-8151
Bonita DurnaśDepartment of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University, IX Wieków Kielc 19A, 25-317 Kielce, Poland.
Angelika MańkowskaDepartment of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University, IX Wieków Kielc 19A, 25-317 Kielce, Poland.
Grzegorz KrólDepartment of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University, IX Wieków Kielc 19A, 25-317 Kielce, Poland.
Tomasz WollnyHoly Cross Oncology Center of Kielce, Artwińskiego 3, 25-734 Kielce, Poland.
Robert BuckiDepartment of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University, IX Wieków Kielc 19A, 25-317 Kielce, Poland.ORCID 0000-0001-7664-9226
Jan Kochanowski University · PLHoly Cross University · PLMedical University of Białystok · PL

Funding

Ministry of Science and Higher Education 024 / RID / 2018/19Project project SUPB.RN.21.155
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer patientsinfectionsnew antibioticsPseudomonas aeruginosa

Identifiers

PMID35745533
PMCPMC9230571
OpenAlexW4282572436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.